Skip to main
OVV

Ovintiv (OVV) Stock Forecast & Price Target

Ovintiv (OVV) Analyst Ratings

Based on 17 analyst ratings
Buy
Strong Buy 35%
Buy 47%
Hold 18%
Sell 0%
Strong Sell 0%

Bulls say

Ovintiv is well-positioned for growth with its focus on its highly attractive assets in the Permian and Montney regions, and the recent NuVista acquisition has further strengthened its portfolio. The company's strong operational execution, deep inventory, and attractive valuation make it a top pick in the E&P sector. Additionally, the company's revised capital allocation framework, including a share buyback program, shows a commitment to shareholder returns. Ovintiv's quarterly results have consistently exceeded expectations, and its strong cash flow generation further supports its position as a top performer in the industry.

Bears say

Ovintiv is a large E&P company focusing on developing its core plays in the Permian and Montney regions of North America. Despite trading at a fair valuation and a premium to proved developed value, Ovintiv has a negative outlook due to risks of quicker than expected development of infrastructure in Canada and weaker than expected performance from newly acquired assets. The company is trading at 187% of its fully loaded Proved Developed Producing Reserves NAV estimate, which includes adjustments for PDP reserves of acquired assets and estimates for divested assets.

Ovintiv (OVV) has been analyzed by 17 analysts, with a consensus rating of Buy. 35% of analysts recommend a Strong Buy, 47% recommend Buy, 18% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Ovintiv and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Ovintiv (OVV) Forecast

Analysts have given Ovintiv (OVV) a Buy based on their latest research and market trends.

According to 17 analysts, Ovintiv (OVV) has a Buy consensus rating as of Aug 8, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $66.29, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $66.29, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Ovintiv (OVV)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.